Search

Meeting Coverage:

American Glaucoma Society

AGS: 2024

Standalone Procedure for Administration of Travoprost Intraocular Implant is Safe and Effective in Phakic Eyes

Steven R. Sarkisian Jr, MD

Show Description +

Steven R. Sarkisian Jr, MD, speaks from the American Glaucoma Society annual meeting to describe a study that isolated a sub-group of phakic patients from a phase 3 trial on the standalone use of the travoprost intraocular implant. He outlines how the device demonstrates safety and pressure control in this group.

Posted: 3/19/2024

Up Next

Scan Me, Scan Me Not: How Best to Use OCT for Glaucoma Screening or Establishing a Diagnosis?

Scan Me, Scan Me Not: How Best to Use OCT for Glaucoma Screening or Establishing a Diagnosis?

Sanjay G. Asrani, MD

IOL Calculation and Astigmatism Management in the Setting of Traditional Glaucoma Surgery

IOL Calculation and Astigmatism Management in the Setting of Traditional Glaucoma Surgery

Aakriti Garg Shukla, MD

Speaking a Patient’s Language

Speaking a Patient’s Language

David A. Solá-Del Valle, MD

AI Implementation: More Than Meets the Eye

AI Implementation: More Than Meets the Eye

Benjamin Xu, Md, PhD

$Use of Wavefront Analysis and Optimizing Refractive Outcomes in Phaco/MIGS$

Use of Wavefront Analysis and Optimizing Refractive Outcomes in Phaco/MIGS

Sahar Bedrood, MD, PhD

Practical Recommendations on Telehealth Implementation

Practical Recommendations on Telehealth Implementation

April Maa, MD

Three Techniques for Guidewire-Assisted Sulcus Tube Entry

Three Techniques for Guidewire-Assisted Sulcus Tube Entry

Mary Qiu, MD

Hyphema Management During MIGS

Hyphema Management During MIGS

Arsham Sheybani, MD

Accidentally Cut Tube During Insertion

Accidentally Cut Tube During Insertion

Cara E. Capitena Young, MD

Back to All Videos

Standalone Procedure for Administration of Travoprost Intraocular Implant is Safe and Effective in Phakic Eyes

Steven R. Sarkisian Jr, MD

Steven R. Sarkisian Jr, MD, speaks from the American Glaucoma Society annual meeting to describe a study that isolated a sub-group of phakic patients from a phase 3 trial on the standalone use of the travoprost intraocular implant. He outlines how the device demonstrates safety and pressure control in this group.

Posted: 3/19/2024

Please log in to leave a comment.

More From AGS: 2024 Coverage

Scan Me, Scan Me Not: How Best to Use OCT for Glaucoma Screening or Establishing a Diagnosis?

Scan Me, Scan Me Not: How Best to Use OCT for Glaucoma Screening or Establishing a Diagnosis?

Sanjay G. Asrani, MD

IOL Calculation and Astigmatism Management in the Setting of Traditional Glaucoma Surgery

IOL Calculation and Astigmatism Management in the Setting of Traditional Glaucoma Surgery

Aakriti Garg Shukla, MD

Speaking a Patient’s Language

Speaking a Patient’s Language

David A. Solá-Del Valle, MD

AI Implementation: More Than Meets the Eye

AI Implementation: More Than Meets the Eye

Benjamin Xu, Md, PhD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2024.